Additionally, GLP-1 slows down the rate at which the stomach empties, leading to prolonged feelings of fullness and reduced appetite
More melanin means more protection from UV radiation, and therefore a healthier (and conveniently, deeper) complexion
Originally developed to treat type 2 diabetes, GLP-1 medications have become wildly popular due to their ability to help people lose weight by slowing digestion and reducing appetite
Semaglutide provides significant appetite reduction
In a July 2024 retrospective, electronic health record (EHR) study in 41,222 adults with overweight or obesity treated for type 2 diabetes, 81.8% of people receiving tirzepatide (Mounjaro) lost at least 5% of their weight within one year compared to 66.5% of those using semaglutide (Ozempic), a significant difference (which means it did not just happen by chance)
And I've been looking forward to this for a long time